A million patients with obesity are already taking Novo Nordisk’s Wegovy pill, CEO Mike Doustdar said Wednesday, despite the market entry of Lilly’s Foundayo.
READ MOREPfizer is staving off Vyndamax competition for another two years.
READ MOREThe FDA has narrowed its search for a new leader of its Center for Biologics Evaluation and Research to three or four final candidates, according to a person familiar with the matter.
READ MOREAfter holding a rally in April, Samsung Biologics union workers on Friday started a five-day strike over wage negotiations.
READ MORE